Daniel K. Spiegelman
Board Member
vTv Therapeutics Inc. (VTVT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel K. Spiegelman
Daniel K. Spiegelman is recorded as Board Member at vTv Therapeutics Inc. (VTVT). Daniel K. Spiegelman was last confirmed as Board Member at Myriad Genetics Inc (MYGN) in a filing dated April 17, 2024. Earlier roles on record: Board Member at Kyverna Therapeutics, Inc. (KYTX) until February 24, 2026. Kyverna Therapeutics, Inc. reported in an 8-K filed February 24, 2026 that Daniel K. Spiegelman resigned as member of the Board and all committees thereof, effective February 24, 2026.
“On February 23, 2026, Daniel Spiegelman notified the Board of his decision to resign from his position as a member of the Board and all committees thereof, effective as of February 24, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
-
2021-01-01–2026-02-24
-
2020-01-01–2024-04-17
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at vTv Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Deepa Prasad CEO, Board Member
- Paul Sekhri CEO, Board Member
- Dr. Jonathan Isaacsohn Chairman
- Jeffrey B. Kindler Chairman
- Robin E. Abrams Chairman
- Barry K. Brown CFO
- Michael Tung CFO
- Barry Brown Chief Accounting Officer
- Anne M. Phillips Board Member
- Anne Phillips Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.